Is Methotrexate Approved for Children?
Yes, methotrexate is FDA-approved for children with specific conditions, including juvenile idiopathic arthritis (JIA), acute lymphoblastic leukemia (ALL), and psoriasis.[1] It's often the first-line disease-modifying antirheumatic drug (DMARD) for JIA in patients as young as 2 years old when methotrexate alone isn't enough.[2]
What Conditions Does It Treat in Kids?
- Juvenile idiopathic arthritis (JIA): Weekly low-dose oral or subcutaneous methotrexate (typically 10-15 mg/m²) reduces joint inflammation and slows disease progression. Studies show 40-70% of children respond well within 3-6 months.[2][3]
- Cancer, especially ALL: High-dose intravenous methotrexate is standard in pediatric protocols, crossing the blood-brain barrier to target central nervous system involvement.[1]
- Other uses: Off-label for severe atopic dermatitis, lupus, or Crohn's disease in children when benefits outweigh risks.[4]
How Is It Dosed and Administered for Children?
Dosing is weight- or body surface area-based:
- JIA: 15 mg/m²/week (max 25 mg), subcutaneous preferred for better absorption and fewer GI side effects.[2]
- ALL: 1-5 g/m² every 2 weeks during maintenance, with leucovorin rescue to reduce toxicity.[1]
Monitoring includes baseline blood tests (CBC, liver enzymes, creatinine) every 1-3 months, with folic acid supplementation (1 mg/day) to cut side effects by 75%.[3]
What Side Effects Should Parents Watch For?
Common issues mirror adults but hit growing kids harder:
- Nausea, vomiting, mouth sores (mitigated by folic acid).
- Liver enzyme elevations (5-10% risk of fibrosis long-term).
- Bone marrow suppression (monitor WBC/platelets).
- Rare: Pneumonitis, infections. Growth delay possible with high cumulative doses.[3][4]
Kids tolerate it better than adults short-term, but annual liver biopsies may be needed for high-risk cases.
Are There Special Risks or Contraindications for Kids?
Avoid in pregnancy (teratogenic, causes neural tube defects) or breastfeeding. Contraindicated with active infections, alcoholism, or severe liver/kidney disease. Vaccinations (live ones) paused during treatment. Long-term cancer risk debated but low in rheumatic doses.[2][4]
How Does It Compare to Alternatives for Children?
| Treatment | Use in Kids | Pros vs. Methotrexate | Cons vs. Methotrexate |
|-----------|-------------|-----------------------|-----------------------|
| Etanercept (Enbrel) | JIA | Faster symptom relief | Injectable, costlier ($20K+/year), infection risk |
| Adalimumab (Humira) | JIA, Crohn's | Targets TNF better in non-responders | Biosimilars emerging, but still expensive |
| Sulfasalazine | Mild JIA | Oral, cheaper | Less effective for polyarticular JIA |
| Cyclosporine | Psoriasis | Quick for skin | Kidney toxicity, not for joints |
Methotrexate remains cheapest ($10-50/month generic) and foundational.[3]
Who Prescribes It and What Do Guidelines Say?
Pediatric rheumatologists or oncologists typically prescribe, following ACR (for JIA) or COG (for ALL) guidelines. It's not over-the-counter—requires specialist oversight.[2]
[1]: FDA Label - Methotrexate (https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011669s111lbl.pdf)
[2]: American College of Rheumatology JIA Guidelines (https://www.rheumatology.org/Portals/0/Files/JIA-Guideline-2019.pdf)
[3]: UpToDate - Methotrexate in Pediatric Rheumatic Disease (https://www.uptodate.com/contents/methotrexate-in-rheumatic-diseases)
[4]: Pediatric Rheumatology Journal Review (https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-020-00431-2)